$GNTX
GENTEX CORP Stock $gntx

$gntx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000035581123000033 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$583.5M	$550.8M
YoY Change	25.91%	17.62%
Cost Of Revenue	$390.4M	$376.0M
YoY Change	23.91%	22.15%
Gross Profit	$193.1M	$174.7M
YoY Change	30.14%	8.93%
Gross Profit Margin	33.09%	31.73%
Selling, General & Admin	$27.82M	$26.83M
YoY Change	-6.39%	6.77%
% of Gross Profit	14.41%	15.36%
Research & Development	$37.97M	$34.65M
YoY Change	15.57%	8.38%
% of Gross Profit	19.67%	19.83%
Depreciation & Amortization	$24.80M	$24.04M
YoY Change	-2.13%	-2.71%
% of Gross Profit	12.84%	13.76%
Operating Expenses	$65.79M	$61.49M
YoY Change	5.14%	7.67%
Operating Profit	$127.3M	$113.3M
YoY Change	48.37%	9.63%
Interest Expense	$2.891M	$2.939M
YoY Change	214.14%	272.84%
% of Operating Profit	2.27%	2.6%
Other Income/Expense, Net	-$1.577M	$2.744M
YoY Change	60.38%	-26252.61%
Pretax Income	$128.6M	$116.0M
YoY Change	51.64%	12.29%
Income Tax	$19.45M	$18.42M
% Of Pretax Income	15.12%	15.88%
Net Earnings	$107.5M	$97.58M
YoY Change	48.52%	11.48%
Net Earnings / Revenue	18.43%	17.72%
Basic Earnings Per Share	$0.47	$0.42
Diluted Earnings Per Share	$0.47	$0.42
COMMON SHARES
Basic Shares Outstanding	233.7M shares	234.2M shares
Diluted Shares Outstanding	230.2M shares	230.9M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$257.8M	$241.1M
YoY Change	-8.36%	-15.88%
Cash & Equivalents	$237.7M	$215.5M
Short-Term Investments	$20.17M	$25.64M
Other Short-Term Assets	$27.03M	$29.32M
YoY Change	-37.91%	18.53%
Inventory	$390.0M	$401.8M
Prepaid Expenses
Receivables	$350.4M	$332.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.025B	$1.005B
YoY Change	3.37%	5.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$596.7M	$575.3M
YoY Change	22.04%	22.81%
Goodwill	$313.6M	$313.7M
YoY Change	-0.07%	-0.08%
Intangibles	$209.7M	$214.5M
YoY Change	-8.43%	-8.41%
Long-Term Investments	$239.6M	$21.50M
YoY Change	500.56%	-87.77%
Other Assets	$28.94M	$853.0M
YoY Change	-96.4%	12.77%
Total Long-Term Assets	$1.462B	$1.428B
YoY Change	13.09%	16.61%
TOTAL ASSETS
Total Short-Term Assets	$1.025B	$1.005B
Total Long-Term Assets	$1.462B	$1.428B
Total Assets	$2.487B	$2.433B
YoY Change	8.87%	11.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$168.5M	$166.9M
YoY Change	-9.73%	18.48%
Accrued Expenses	$107.6M	$130.1M
YoY Change	8.09%	32.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$276.1M	$297.0M
YoY Change	-3.53%	24.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$15.10M	$13.06M
YoY Change	28.94%	7.15%
Total Long-Term Liabilities	$15.10M	$13.06M
YoY Change	28.94%	7.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$276.1M	$297.0M
Total Long-Term Liabilities	$15.10M	$13.06M
Total Liabilities	$291.2M	$310.1M
YoY Change	-2.26%	23.34%
SHAREHOLDERS EQUITY
Retained Earnings	$1.253B	$1.193B
YoY Change	15.67%	14.88%
Common Stock	$956.7M	$942.3M
YoY Change	4.59%	5.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.196B	$2.123B
YoY Change
Total Liabilities & Shareholders Equity	$2.487B	$2.433B
YoY Change	8.87%	11.6%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$107.5M	$97.58M
YoY Change	48.52%	11.48%
Depreciation, Depletion And Amortization	$24.80M	$24.04M
YoY Change	-2.13%	-2.71%
Cash From Operating Activities	$120.9M	$120.9M
YoY Change	64.87%	4.27%
INVESTING ACTIVITIES
Capital Expenditures	$48.83M	$44.93M
YoY Change	-237.22%	-284.54%
Acquisitions
YoY Change
Other Investing Activities	-$5.164M	-$27.47M
YoY Change	-79.82%	-223.15%
Cash From Investing Activities	-$54.00M	-$72.40M
YoY Change	-11.73%	3441.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-48.64M	-$47.82M
YoY Change	116.51%	-50.45%
NET CHANGE
Cash From Operating Activities	120.9M	$120.9M
Cash From Investing Activities	-54.00M	-$72.40M
Cash From Financing Activities	-48.64M	-$47.82M
Net Change In Cash	18.21M	$697.5K
YoY Change	-276.21%	-95.99%
FREE CASH FLOW
Cash From Operating Activities	$120.9M	$120.9M
Capital Expenditures	$48.83M	$44.93M
Free Cash Flow	$72.02M	$75.98M
YoY Change	-33.86%	-45.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000355811
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-10235
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	GENTEX CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MI
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-2030505
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 N. Centennial
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Zeeland
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	49464
CY2023Q1	dei	City Area Code CityAreaCode	616
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	772-1800
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.06 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	GNTX
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	233702848	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215452160	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214754638	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	4000000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4000000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	25635492	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	23007385	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	332867128	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	276493752	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	401769976	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	404360270	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25316437	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26036331	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1005041193	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	948652376	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	575276023	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	550033036	usd
CY2023Q1	us-gaap	Goodwill Goodwill	313686026	usd
CY2022Q4	us-gaap	Goodwill Goodwill	313807494	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	229398824	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	202331983	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	214535910	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	219360910	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	23795400	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	25528700	usd
CY2023Q1	gntx	Patent And Other Assets Net PatentAndOtherAssetsNet	71614459	usd
CY2022Q4	gntx	Patent And Other Assets Net PatentAndOtherAssetsNet	67515425	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	853030619	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	828544512	usd
CY2023Q1	us-gaap	Assets Assets	2433347835	usd
CY2022Q4	us-gaap	Assets Assets	2327229924	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	166922435	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	151740046	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	130108297	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98812706	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	297030732	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	250552752	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13061457	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10884351	usd
CY2023Q1	us-gaap	Liabilities Liabilities	310092189	usd
CY2022Q4	us-gaap	Liabilities Liabilities	261437103	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	14023563	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14050160	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	928284890	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	917499323	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1193171690	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1148386272	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12224497	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14142934	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2123255646	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2065792821	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2433347835	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2327229924	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550761311	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	376024080	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	307838816	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	174737231	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	160411960	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34653747	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31974987	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26832837	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25131068	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	61486584	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	57106055	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	113250647	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	103305905	usd
CY2023Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2939195	usd
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	788316	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-194740	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-798810	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2744455	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10494	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	115995102	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103295411	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18416841	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15766785	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	97578261	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.120
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.120
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	97578261	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-121167	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-896420	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2581777	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7795230	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	2460610	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-8691650	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	542173	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1636998	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1918437	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7054652	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	99496698	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	80473974	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2065792821	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5956022	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28462632	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8519535	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28046798	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	97578261	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1918437	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2123255646	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1937988467	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3324147	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	71252022	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6788337	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28354003	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7054652	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1928968900	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	97578261	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24041648	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24711500	usd
CY2023Q1	gntx	Gain On Disposal Of Assets GainOnDisposalOfAssets	106743	usd
CY2022Q1	gntx	Gain On Disposal Of Assets GainOnDisposalOfAssets	33982	usd
CY2023Q1	gntx	Loss On Disposition Of Assets LossOnDispositionOfAssets	41843	usd
CY2022Q1	gntx	Loss On Disposition Of Assets LossOnDispositionOfAssets	11067	usd
CY2023Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1199707	usd
CY2022Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	367879	usd
CY2023Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	1671583	usd
CY2022Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	704214	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	141959	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8519535	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6788337	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	56373376	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	31666772	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2590294	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	46469079	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	629502	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16082077	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11112425	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	42968193	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	33525890	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15702241	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	120914110	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115958543	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3128110	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	37158611	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1465000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1000000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	32178155	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	15889063	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	42819075	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	23892169	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	118410	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	33740	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2110935	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	455419	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72396645	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2044300	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5956022	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3324147	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28099993	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28589625	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25675972	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	71252022	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47819943	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-96517500	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	697522	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17396743	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218754638	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262311670	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	219452160	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	279708413	usd
CY2023Q1	us-gaap	Goodwill Goodwill	313700000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	313800000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	313807494	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-121468	usd
CY2023Q1	us-gaap	Goodwill Goodwill	313686026	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5300000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5500000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	21500000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	215452160	usd
CY2023Q1	gntx	Restricted Cash Fair Value Disclosure RestrictedCashFairValueDisclosure	4000000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	385996220	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	214754638	usd
CY2022Q4	gntx	Restricted Cash Fair Value Disclosure RestrictedCashFairValueDisclosure	4000000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	378544756	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	176760632	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	337710	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10554281	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	166544061	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	172587805	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	236375	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	13034062	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	159790118	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	321165	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	23213314	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10233116	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	130046373	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	10554281	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	153259687	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4816103	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	77701146	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	8217959	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	76643586	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	13034062	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	154344732	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	301876129	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	304184004	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	44534016	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	45512275	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	55359831	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	54663991	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	401769976	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	404360270	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	97578261	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1456913	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1360047	usd
CY2023Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	96121348	usd
CY2022Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	86168579	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230605626	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232151296	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2023Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	96121348	usd
CY2022Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	86168579	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-1276	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-2500	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	96122624	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	86171079	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230605626	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232151296	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	290220	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	638515	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	230895846	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232789811	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1810685	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1572223	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8519535	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6788337	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0176
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0180
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2904
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2816
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0360
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0242
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M24D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.84
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.38
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	600000	shares
CY2023Q1	gntx	Net Increase Decrease In Common Stock Shares From Shares Issued In Share Based Compensation And Shares Repurchased NetIncreaseDecreaseInCommonStockSharesFromSharesIssuedInShareBasedCompensationAndSharesRepurchased	-400000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2023Q1	us-gaap	Dividends Dividends	28000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550761311	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	863358	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	492746	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	113250647	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	103305905	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.153
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550761311	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1291999	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	84795	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	978	usd
CY2023Q1	gntx	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2733876	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	87129	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2646747	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1572606	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1074141	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2646747	usd

Files In Submission

Name	View Source	Status
0000355811-23-000033-index-headers.html	Edgar Link	pending
0000355811-23-000033-index.html	Edgar Link	pending
0000355811-23-000033.txt	Edgar Link	pending
0000355811-23-000033-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gntx-20230331.htm	Edgar Link	pending
gntx-20230331.xsd	Edgar Link	pending
gntx10q03312023-exx311.htm	Edgar Link	pending
gntx10q03312023-exx312.htm	Edgar Link	pending
gntx10q03312023-exx32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
gntx-20230331_cal.xml	Edgar Link	unprocessable
gntx-20230331_def.xml	Edgar Link	unprocessable
gntx-20230331_lab.xml	Edgar Link	unprocessable
gntx-20230331_pre.xml	Edgar Link	unprocessable
gntx-20230331_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNTX
GENTEX CORP Stock $gntx

2023 Q2 Form 10-Q Financial Statement

#000035581123000033 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX GENTEX CORP Stock $gntx

2023 Q2 Form 10-Q Financial Statement

#000035581123000033 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX
GENTEX CORP Stock $gntx